Back to Results
First PageMeta Content
Pharmaceutical sciences / Chemistry / AstraZeneca / Södertälje Municipality / Pharmaceutical industry / Pharmaceutical drug / Quetiapine / Strategic management / Corporate social responsibility / Business / Pharmacology / Management


Pioneering science, life-changing medicines AstraZeneca Annual Report and Form 20-F Information 2013 2 6
Add to Reading List

Document Date: 2014-04-03 06:39:00

Open Document

File Size: 2,95 MB

Share Result on Facebook

City

Gaithersburg / Cambridge / /

Company

Pearl Therapeutics / BMS / AstraZeneca US / Supply / Page 16 Manufacturing / Sales and Marketing / Dow Jones / FibroGen / Omthera / Amylin / Executive Officer / /

Continent

Europe / Africa / North America / /

Country

Japan / United Kingdom / China / Sweden / Russia / United States / /

Currency

SEK / USD / pence / /

Event

Business Partnership / FDA Phase / Security Buyback / M&A / Funding / Dividend Issuance / Person Travel / Product Recall / Reorganization / Employment Change / Earnings Guidance / Product Issues / /

Facility

headquarters AstraZeneca / AstraZeneca US Court of Appeals for the Federal Circuit / Development Pipeline / University of Cambridge / RNA Therapeutics Cambridge Biomedical Campus / /

IndustryTerm

value chain / pharmaceutical sector norm / manufacturing / manufacturing site / healthcare costs / diabetes treatment / innovation-driven biopharmaceutical / antibody-drug conjugate technology / healthcare / pure-play biopharmaceutical / online conversation / pharmaceutical market / /

MarketIndex

SET / /

MedicalCondition

potential cancer / rheumatoid arthritis / cardiovascular and metabolic disease / gout / chronic kidney disease / end-stage renal disease / cardiovascular diseases / breast cancer / asthma / partial lipodystrophy / lipodystrophy / Cancer / schizophrenia / diabetes / opioid-induced constipation / Infection / respiratory infection / severe asthma / COPD / business’s global diabetes / Gastrointestinal (ING) disease / joint diabetes / diabetes EC / hypertension / heart failure / Metabolic disease / Inflammation / bipolar disorder / /

MedicalTreatment

immunotherapy / /

Movie

Hand in hand / /

Organization

World Health Organization / Audit Committee / Board of Directors and Senior Executive Team Page / Remuneration Committee / FDA / AstraZeneca US Court of Appeals / European Union / EC FDA Advisory Committee / Johns Hopkins University / University of Cambridge / SET / /

Person

Lynn Tetrault / Rudy Markham / Leif Johansson / Marc Dunoyer / Caroline Hempstead / Simon Lowth / Ruud Dobber / Pascal Soriot / John Varley / Pearl Therapeutics / /

Position

Chairman Strategic Report / Auditor / CEO / Executive / pioneering messenger / Annual General / Chief Financial Officer / glance Chairman / Strategic Report Chief / Chairman / CFO and Executive Director / Statement Chief / /

Product

Synagis / Nexium / Crestor / Symbicort / Zoladex / Toprol-XL / Iressa / Atacand / Seroquel XR / projects / Faslodex / Pulmicort Respules / Seroquel / Pulmicort / Arimidex / EU / US / /

RadioStation

Core / WHO 2 / /

Region

Middle East / Central America / South America / Asia Pacific / /

Technology

Neuroscience / antibody-drug conjugate technology / /

SocialTag